ARGA Investment Management LP grew its position in shares of Humana Inc. (NYSE:HUM – Free Report) by 311.0% in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 221,917 shares of the insurance provider’s stock after buying an additional 167,926 shares during the quarter. Humana accounts for 1.5% of ARGA Investment Management LP’s investment portfolio, making the stock its 17th largest holding. ARGA Investment Management LP owned 0.18% of Humana worth $57,736,000 at the end of the most recent reporting period.
Several other hedge funds also recently added to or reduced their stakes in the stock. Elevation Point Wealth Partners LLC purchased a new position in shares of Humana in the second quarter valued at $32,000. Mather Group LLC. acquired a new stake in Humana during the 3rd quarter valued at approximately $34,000. Private Wealth Management Group LLC increased its holdings in Humana by 47.5% during the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares during the last quarter. AlphaCore Capital LLC purchased a new stake in Humana during the 2nd quarter worth approximately $39,000. Finally, SJS Investment Consulting Inc. raised its position in shares of Humana by 19,300.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after purchasing an additional 193 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of brokerages recently issued reports on HUM. Guggenheim restated a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Truist Financial decreased their price objective on shares of Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Bank of America upped their target price on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a research note on Friday, October 10th. Mizuho increased their price target on shares of Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Finally, Sanford C. Bernstein reissued an “outperform” rating and issued a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $293.37.
Humana Stock Down 0.2%
HUM stock opened at $265.68 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The firm has a market cap of $31.95 billion, a PE ratio of 24.90, a P/E/G ratio of 2.19 and a beta of 0.45. The firm has a 50 day simple moving average of $258.26 and a 200 day simple moving average of $264.47. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35.
Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, beating analysts’ consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the prior year, the firm earned $4.16 earnings per share. Equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.3%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s dividend payout ratio is presently 33.18%.
About Humana
Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
See Also
- Five stocks we like better than Humana
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- A U.S. “birthright” claim worth trillions – activated quietly
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.
